170 related articles for article (PubMed ID: 24294361)
1. Potential biomarkers for paclitaxel sensitivity in hypopharynx cancer cell.
Xu CZ; Shi RJ; Chen D; Sun YY; Wu QW; Wang T; Wang PH
Int J Clin Exp Pathol; 2013; 6(12):2745-56. PubMed ID: 24294361
[TBL] [Abstract][Full Text] [Related]
2. Gene and microRNA expression reveals sensitivity to paclitaxel in laryngeal cancer cell line.
Xu CZ; Xie J; Jin B; Chen XW; Sun ZF; Wang BX; Dong P
Int J Clin Exp Pathol; 2013; 6(7):1351-61. PubMed ID: 23826416
[TBL] [Abstract][Full Text] [Related]
3. Array analysis for potential biomarker of gemcitabine identification in non-small cell lung cancer cell lines.
Zhang HH; Zhang ZY; Che CL; Mei YF; Shi YZ
Int J Clin Exp Pathol; 2013; 6(9):1734-46. PubMed ID: 24040438
[TBL] [Abstract][Full Text] [Related]
4. AKT/ERK activation is associated with gastric cancer cell resistance to paclitaxel.
Wu G; Qin XQ; Guo JJ; Li TY; Chen JH
Int J Clin Exp Pathol; 2014; 7(4):1449-58. PubMed ID: 24817940
[TBL] [Abstract][Full Text] [Related]
5. MiR-634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo.
Peng X; Cao P; He D; Han S; Zhou J; Tan G; Li W; Yu F; Yu J; Li Z; Cao K
Int J Clin Exp Pathol; 2014; 7(10):6784-91. PubMed ID: 25400759
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.
Jeong JY; Kang H; Kim TH; Kim G; Heo JH; Kwon AY; Kim S; Jung SG; An HJ
Cancer Lett; 2017 Feb; 386():168-178. PubMed ID: 27887917
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
[TBL] [Abstract][Full Text] [Related]
8. Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation.
Drago-Ferrante R; Pentimalli F; Carlisi D; De Blasio A; Saliba C; Baldacchino S; Degaetano J; Debono J; Caruana-Dingli G; Grech G; Scerri C; Tesoriere G; Giordano A; Vento R; Di Fiore R
Oncotarget; 2017 Apr; 8(17):28939-28958. PubMed ID: 28423652
[TBL] [Abstract][Full Text] [Related]
9. DNA microarray reveals different pathways responding to paclitaxel and docetaxel in non-small cell lung cancer cell line.
Che CL; Zhang YM; Zhang HH; Sang YL; Lu B; Dong FS; Zhang LJ; Lv FZ
Int J Clin Exp Pathol; 2013; 6(8):1538-48. PubMed ID: 23923072
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
11. MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo.
Peng X; Cao P; Li J; He D; Han S; Zhou J; Tan G; Li W; Yu F; Yu J; Li Z; Cao K
Cancer Biol Ther; 2015; 16(2):261-7. PubMed ID: 25756509
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR.
Zhang B; Zhao R; He Y; Fu X; Fu L; Zhu Z; Fu L; Dong JT
Oncotarget; 2016 Feb; 7(5):5702-14. PubMed ID: 26744318
[TBL] [Abstract][Full Text] [Related]
13. New Insights in Gene Expression Alteration as Effect of Paclitaxel Drug Resistance in Triple Negative Breast Cancer Cells.
Jurj A; Pop LA; Zanoaga O; Ciocan-Cârtiţă CA; Cojocneanu R; Moldovan C; Raduly L; Pop-Bica C; Trif M; Irimie A; Berindan-Neagoe I; Braicu C
Cell Physiol Biochem; 2020 Jul; 54(4):648-664. PubMed ID: 32619350
[TBL] [Abstract][Full Text] [Related]
14. miR-17-5p downregulation contributes to paclitaxel resistance of lung cancer cells through altering beclin1 expression.
Chatterjee A; Chattopadhyay D; Chakrabarti G
PLoS One; 2014; 9(4):e95716. PubMed ID: 24755562
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells.
Miyamoto M; Sawada K; Nakamura K; Yoshimura A; Ishida K; Kobayashi M; Shimizu A; Yamamoto M; Kodama M; Hashimoto K; Kimura T
Sci Rep; 2020 Oct; 10(1):16755. PubMed ID: 33028939
[TBL] [Abstract][Full Text] [Related]
16. Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma.
Li X; Pan Q; Wan X; Mao Y; Lu W; Xie X; Cheng X
BMC Cancer; 2015 Jul; 15():509. PubMed ID: 26152689
[TBL] [Abstract][Full Text] [Related]
17. Effect of rs67085638 in long non-coding RNA (CCAT1) on colon cancer chemoresistance to paclitaxel through modulating the microRNA-24-3p and FSCN1.
Xiao ZS; Zhao L; Zhang XN; Li HX; Yin ZH
J Cell Mol Med; 2021 Apr; 25(8):3744-3753. PubMed ID: 33709519
[TBL] [Abstract][Full Text] [Related]
18. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.
Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863
[TBL] [Abstract][Full Text] [Related]
19. A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis.
Vecchione A; Belletti B; Lovat F; Volinia S; Chiappetta G; Giglio S; Sonego M; Cirombella R; Onesti EC; Pellegrini P; Califano D; Pignata S; Losito S; Canzonieri V; Sorio R; Alder H; Wernicke D; Stoppacciaro A; Baldassarre G; Croce CM
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9845-50. PubMed ID: 23697367
[TBL] [Abstract][Full Text] [Related]
20. Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel.
Chen N; Chon HS; Xiong Y; Marchion DC; Judson PL; Hakam A; Gonzalez-Bosquet J; Permuth-Wey J; Wenham RM; Apte SM; Cheng JQ; Sellers TA; Lancaster JM
Oncol Rep; 2014 Jan; 31(1):376-83. PubMed ID: 24220856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
